KOHEN AVOCATS · PARIS, FRANCE
Medicare multiple doctor visits rule: can your doctor make you come back for a second visit in 2027?

Hassan Kohen is a Paris-based lawyer admitted to the Paris Bar (Avocat au Barreau de Paris). Initial strategic analysis: €80 incl. VAT, personal reply within 24 hours.

100% confidential · Legal professional privilege · No obligation

Article generated by artificial intelligence, through a process designed and supervised by the firm

Sources: U.S. court opinions and official U.S. government publications, read for this article

Maître Hassan KOHEN, avocat au Barreau de Paris
Hassan KOHEN
Attorney at the Paris Bar

Medicare multiple doctor visits rule: can your doctor make you come back for a second visit in 2027?

Speak to a lawyer 06 89 11 34 45

People searching for the Medicare multiple doctor visits rule this week have usually heard a worrying version of the story: starting in 2027, Medicare will supposedly force patients to come back on another day for the biopsy, the joint injection or the lesion removal that used to happen during the same appointment. The official text says something narrower. The Centers for Medicare & Medicaid Services (CMS) published its calendar year 2027 Physician Fee Schedule final rule in the Federal Register on November 9, 2026, at 91 FR 70992, effective January 1, 2027 (CY 2027 Physician Fee Schedule final rule). When an office or outpatient visit and a procedure with a 0-day global period are furnished on the same day by the same practitioner, or by a practitioner of the same specialty in the same group, the highest-value service is paid in full and the others are paid 20 percent less. CMS summarizes the result as payment at 100% for the most expensive service and 80% for the rest (CMS fact sheet on the final rule). This is a federal payment rule for doctors billing Original Medicare under Part B. It does not cap your visits, and CMS wrote that splitting care across two days would raise, not lower, what patients pay. Below: what changes, what to check on your bill, and why a lawsuit against the rule itself would face a steep federal statute and three decisions that point the same way.

I. What does the 2027 Medicare rule actually change when you see your doctor?

A. A payment cut for the doctor, not a limit on the patient

Under federal law, payment for a physician’s service under Medicare Part B is based on the lesser of the actual charge or the amount set by the annual fee schedule, as 42 U.S.C. § 1395w-4(a)(1) provides (42 U.S.C. § 1395w-4, payment for physicians’ services). Each year CMS revises that schedule by regulation. The 2027 change targets a specific billing pattern. Many minor procedures, such as shaving a skin lesion or another quick in-office service, are priced as a “global” package that already includes the routine evaluation that happens before and after the procedure. A separate office visit may still be billed on the same day when it is significant and separately identifiable, and the claim then carries a code modifier known as modifier 25. CMS’s view, set out in the final rule, is that the two payments partly overlap and that Medicare has been paying twice for some of the same work.

The proposal published in July 2026 was much broader than what CMS finally adopted. It would have cut the lower-priced services by 50 percent and applied to procedures with 0-day, 10-day and 90-day global periods. After an “overwhelming response” from commenters, CMS stated in the final rule that it was “finalizing a 20 percent reduction in payment to all services except the highest value service” when the office visit is performed on the same day as a service with a 0-day global period. The reduction applies only to office and outpatient evaluation and management visits; CMS confirmed that it does not apply to inpatient visits, and it dropped 10-day and 90-day procedures from the policy. CMS also narrowed who counts as the same practitioner: a visit with one physician and a procedure by a colleague of a different specialty in the same group does not trigger the cut. For patients who see a dermatologist and a cardiologist in the same building on the same afternoon, that clarification matters.

The most useful sentence for patients appears in CMS’s response to comments: “this policy does not prohibit same-day procedures from occurring with an office visit.” CMS added that it had received patient letters and photographs of office notices stating that Medicare would no longer pay for same-day procedures, and it wrote that “practitioners who are directly misleading their patients are not operating in good faith of the doctor-patient relationship.” The agency also repeated that it does not find it appropriate to schedule medical services to maximize payment, and it listed the tools it plans to use to watch for that practice: claims edits, comparative billing reports sent to outlier providers, and medical review. That is the federal agency’s own reading of its rule, published in the Federal Register, and it is the document to point to if a front desk tells you that Medicare forbids treating you today.

Several limits keep this from being the whole story. First, the rule changes what Medicare pays the practice, so a physician may still decide, for clinical or business reasons, to schedule a procedure for another day. Nothing in the rule requires a doctor to perform a procedure on the same day as the visit. Second, the final rule describes CMS’s monitoring tools; it does not create a new patient right to demand same-day care. Third, CMS deferred any special treatment of eye injections given with a same-day eye exam: it collected comments on intravitreal injections and said it would consider them in future rulemaking. Fourth, the rule takes effect on January 1, 2027, so a bill for a visit in December 2026 is not affected by it.

A practical way to use this information is to ask a direct question when a second appointment is proposed: is the second visit medically necessary for me, or is it being scheduled because of the payment change? A clinician may have legitimate reasons to separate an evaluation and a procedure, such as the need for test results, consent, a different room or equipment, or the patient’s own condition. Those reasons belong in your medical record. A vague statement that “Medicare won’t allow it” is not a reason the 2027 rule supplies, because CMS wrote the opposite.

B. What a split visit can mean for your bill

Cost-sharing explains why CMS took the position it did. For physicians’ services, federal law fixes the amount Medicare pays at 80 percent of the payment basis determined under the fee schedule section, as 42 U.S.C. § 1395l(a)(1)(N) states (42 U.S.C. § 1395l, payment of benefits). The beneficiary’s share in Original Medicare is generally the remaining 20 percent coinsurance, after the annual Part B deductible. In the final rule, CMS agreed with commenters who said cost-sharing would decrease under the policy, a point those commenters tied to the 20 percent coinsurance patients generally pay, and it added that if practitioners bring patients back another day for their procedure, this “would actually increase beneficiary cost-sharing.” In plain terms, two separately billed encounters usually mean two separately computed patient shares, plus the time, travel and caregiver costs that commenters described.

If you are charged after January 1, 2027, compare three documents: the provider’s bill, the Medicare Summary Notice for the same date of service, and any written explanation the office gave you for a second appointment. The Summary Notice shows what Medicare approved and what it says you may owe. If the deductible or coinsurance seems to have been applied twice to what was really one encounter, our guide on challenging a 2027 Medicare Part B deductible charge that was counted incorrectly walks through how to match each line and what to file. Keep the office’s letter or a photograph of any posted notice; CMS cited exactly such letters as a concern.

Patients whose physician does not participate in Medicare have an additional protection set by the statute itself. Under 42 U.S.C. § 1395w-4(g), a nonparticipating physician who does not accept assignment may not bill or collect more than the “limiting charge” for the service, and the patient is not liable for amounts billed above it. For services after 1992, the statute sets that limiting charge at 115 percent of the recognized payment amount for nonparticipating physicians (42 U.S.C. § 1395w-4(g)). If a provider collects more than the limit, the same subsection requires a timely refund of the excess. The passages of the final rule read for this article do not say how the limiting charge is computed for a service whose payment was reduced because it was furnished the same day as another. If a non-assigning physician bills you for such a service, ask the office which amount it used as the base, and compare that answer with the approved amount shown on your Medicare Summary Notice.

What if you believe a practice is splitting appointments only to avoid the reduction, or billing for an evaluation that never happened? CMS said it intends to monitor these patterns. In the section devoted to this policy, it describes its monitoring tools and a request for comment on whether conditions of payment should be revised; it does not announce a new condition of payment there. A patient’s role is limited to reporting what happened and keeping the paperwork. Our explainer on how to report Medicare billing fraud and what happens after you file covers that step. Scheduling a second visit is not, by itself, fraud. The question is whether the bill describes services that were actually furnished and medically justified.

Three further practical points follow from the texts read for this article. The same-day reduction is part of the Physician Fee Schedule used to pay claims in Original Medicare, and this article addresses that program; a Medicare Advantage member should check the plan’s own cost-sharing documents rather than assume that a federal payment change alters a plan copay. The statute’s 80 percent rule for physicians’ services itself excludes personalized prevention plan services, which follow their own cost-sharing rules. And because the rule is federal, the analysis is the same whether you live in Florida, Ohio or California.

II. Can a patient or a doctor challenge the rule, and what have courts decided?

A. Why a lawsuit against the fee schedule itself faces a federal statute

Physician groups opposed the proposal, and some readers want to know whether a court could block it before January 1, 2027. The starting point is the text of the Medicare Act. Section 1395w-4(i)(1) provides that “There shall be no administrative or judicial review under section 1395ff of this title or otherwise of” several fee schedule determinations, including the determination of relative values and relative value units, the conversion factors, the geographic adjustment factors, the coding system, and the collection and use of information in determining relative values (42 U.S.C. § 1395w-4(i)(1)). Note the words “administrative or judicial”: the bar covers the Medicare appeals process as well as the courts. Whether the new same-day reduction is itself a “determination of relative values” under that provision is a question no court has answered in the decisions read for this article. What the courts have decided is how broadly to read the bar when doctors attacked other parts of the fee schedule.

In American Society of Cataract and Refractive Surgery v. Thompson, 279 F.3d 447 (7th Cir. 2002), eleven national medical societies challenged the regulation that implemented a statutory transition formula for practice expense relative value units, a core input of the fee schedule. The U.S. Court of Appeals for the Seventh Circuit, in a decision dated January 28, 2002, affirmed the dismissal of the case. It agreed that the Medicare Act, by its express terms, precludes judicial review of the determination of relative values and relative value units, including review of the regulation implementing the formula, and it rejected the societies’ due process and separation-of-powers arguments. The court also pointed to the structure of Part B: the fee schedule is set every year on a tight timetable and certain adjustments must be budget neutral, so finality matters. For a reader in 2027, the application is direct: a challenge framed as an attack on the values or the methodology behind the fee schedule faces a federal court that has already treated the statutory bar as reaching the regulation, not just individual numbers.

That reading has not faded. In SkinCure Oncology, LLC v. Kennedy, No. 1:26-cv-00737 (D.D.C. April 10, 2026), the United States District Court for the District of Columbia quoted the Seventh Circuit’s 2002 opinion while refusing to block part of the 2026 fee schedule: “It would be difficult for Congress to have written paragraph (B) in clearer terms prohibiting such a challenge.” That citation of 279 F.3d 447 shows the 2002 holding still being applied to a current fee schedule dispute, although a search for later citations is not a complete citator and does not guarantee how every court will rule.

The District of Columbia case is the closest recent comparison to the 2027 controversy. In SkinCure Oncology, LLC v. Kennedy, No. 1:26-cv-00737 (D.D.C. April 10, 2026), a company that supports dermatology practices offering image-guided superficial radiation treatment for non-melanoma skin cancer, a patient advocacy organization and six Medicare Part B enrollees sued over the 2026 Physician Fee Schedule and related local coverage determinations. The United States District Court for the District of Columbia denied their motion for a stay and a preliminary injunction on April 10, 2026. It concluded that the entity plaintiffs’ challenges to the fee schedule failed for two independent reasons: they had to be channeled through the Medicare administrative process, and they essentially attacked relative value units that 42 U.S.C. § 1395w-4(i)(1)(B) makes unreviewable. The court added that arguing about the data source behind the values did not help, because the statute also bars review of the collection and use of information used to set them. For patients, the lesson is that a lawsuit seeking an emergency order against a fee schedule provision faces long odds; the court did recognize that two patient plaintiffs who were seeking treatment had standing, but it held that their claims were subject to the Medicare Act’s channeling requirement and could reach the court only through the statute’s special route for purely legal challenges to local coverage determinations. This was a preliminary ruling, not a final judgment, and the case concerned a coverage and valuation dispute rather than the 2027 same-day reduction.

Two consequences follow for anyone hoping a court will undo the 2027 change for them. First, the realistic forums are the ones Congress created: comments in future rulemaking, which CMS expressly invited, for example through nominations of potentially misvalued codes, and Congress itself. Second, even if a professional association sues, an individual patient’s claim for a specific bill still runs through the Medicare claims process described below. The courts’ reluctance concerns the policy, not your right to have your own claim processed correctly under whatever rule applies on your date of service.

B. The route that remains: the Medicare appeal of your own claim

The second line of cases explains why. Federal law incorporates into Medicare the Social Security Act’s rule that no action to recover on a claim arising under the program may be brought under general federal-question jurisdiction; 42 U.S.C. § 1395ii makes 42 U.S.C. § 405(h) applicable to Medicare (42 U.S.C. § 1395ii; 42 U.S.C. § 405(h)). Judicial review then comes only after a final decision of the Secretary, under section 405(g).

In Shalala v. Illinois Council on Long Term Care, Inc., 529 U.S. 1 (2000), an association of nursing homes went directly to federal district court to challenge Medicare regulations. The Supreme Court of the United States, in a decision dated February 29, 2000, held that section 405(h), as incorporated by section 1395ii, barred federal-question jurisdiction and that the association or its members had to proceed through the special review channel that the Medicare statutes create. The Court explained that the provision requires channeling “virtually all legal attacks through the agency,” accepting that this can cause individual hardship from delay. It recognized an exception only where applying section 405(h) would mean no review at all rather than review through the agency. For a Medicare patient, the application is practical: if you think a 2027 bill was processed wrongly, for example coinsurance computed twice for one encounter or a limiting charge exceeded, you generally must present the claim to Medicare and use the administrative appeal before any federal court will hear it.

That rule is still being enforced in 2026. In Hameed v. U.S. Department of Health and Human Services (No. 25-cv-04117 (DLF), D.D.C. September 29, 2026), the United States District Court for the District of Columbia dismissed a physician’s Administrative Procedure Act claims about the revocation of his Medicare billing privileges. The district court cited Illinois Council, 529 U.S. 1, for the rule that the Medicare framework demands channeling virtually all legal attacks through the agency, and held that it lacked jurisdiction over his claims. That case involved provider enrollment, not a patient’s bill, but it shows the same channeling principle applied by a federal court this year.

The administrative route has firm deadlines, and they are set by statute and regulation rather than by custom. Under 42 U.S.C. § 1395ff(a)(3)(C)(i), a redetermination is available only if the request is filed by the end of the 120-day period beginning on the date the individual receives notice of the initial determination, and the contractor must conclude the redetermination within 60 days of receiving the request (42 U.S.C. § 1395ff, determinations and appeals). The implementing regulation repeats the 120 calendar days, presumes that the notice is received 5 calendar days after its date unless there is evidence to the contrary, and treats the request as filed on the date the contractor receives it (42 CFR 405.942). The same regulation allows an extension for good cause and gives examples such as serious illness or destroyed records. Section 1395ff(b)(1)(A) then provides for reconsideration, a hearing and, after a final decision, judicial review under section 405(g).

Be precise about what such an appeal can and cannot do. It can test whether your claim was processed correctly under the rules in force: whether a service was billed, whether the coinsurance and deductible were applied to the right amounts, and whether a non-assigning physician exceeded the limiting charge. It is not a vehicle for relitigating the policy: section 1395w-4(i)(1) bars administrative as well as judicial review of the fee schedule determinations it lists, and the decisions above read that bar broadly, even though none of them applied it to the 2027 same-day reduction. When you write the request, attach the Medicare Summary Notice, the provider’s bill, the office’s explanation for any second visit and your own short timeline of what happened on each date. Ask a specific question for each disputed line.

Finally, keep the federal framework in view. The amount Medicare pays the physician, the reduction for same-day services and the route for contesting a Medicare claim are set by federal law, and the same steps apply in every state. A patient who receives a notice claiming that Medicare forbids same-day care can raise the Federal Register statement with the practice, keep the notice, and use it in a Medicare appeal where it bears on what was billed. If you are weighing whether a planned procedure should happen at the same appointment, the right conversation is clinical first and financial second, and the 2027 rule does not take that choice away from you or your doctor.

Conclusion

The Medicare multiple doctor visits rule is a payment rule. From January 1, 2027, when an office or outpatient visit and a 0-day global procedure are billed on the same day by the same practitioner or the same specialty in the same group, Medicare pays the highest-value service in full and the others at 80 percent. CMS stated in the Federal Register that the policy does not prohibit same-day procedures, called misleading patient letters concerning, and acknowledged that bringing patients back on another day would increase their cost-sharing. A court challenge to the rule itself would meet a federal statute that bars administrative and judicial review of key fee schedule determinations, and the Seventh Circuit in 2002 and the District of Columbia district court in 2026 both read that bar firmly. What remains in a patient’s hands is concrete: ask why a second visit is needed, compare the bill with the Medicare Summary Notice, watch the limiting charge if your physician does not accept assignment, and file a redetermination request within the 120-day period that 42 U.S.C. § 1395ff sets if a claim was processed wrongly.

📄 Official circular